Rebekah A. Freeman

Conformationally-flexible benzamide analogues as dopamine D3 and σ2 receptor ligands

Robert H. Mach, Yun‐Sheng Huang, Rebekah A. Freeman et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 93 citations · Full text

Molecular Pharmacology, Engineering, Medicine +7

N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl}arylcarboxamides as novel dopamine D3 receptor antagonists

Amy Hauck Newman, Jianjing Cao, Christina Bennett et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 59 citations · Full text

Functional Selectivity, Medicine, Neuropeptide Receptor +5

Characterization of125I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors

Robert R. Luedtke, Rebekah A. Freeman, Virginia A. Boundy et al. · Synapse · 2000 · 49 citations · Full text

D2-like Dopamine Receptors, Medicinal Chemistry, Biochemistry +14

Synthesis of 2-(5-Bromo-2,3-dimethoxyphenyl)-5-(aminomethyl)-1H-pyrrole analogues and their binding affinities for dopamine D2, D3, and D4 receptors

Robert H. Mach, Yun‐Sheng Huang, Rebekah A. Freeman et al. · Bioorganic & Medicinal Chemistry · 2003 · 27 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Biochemistry +11

Synthesis and Structure−Activity Relationships of Naphthamides as Dopamine D₃ Receptor Ligands

Yun‐Sheng Huang, Robert R. Luedtke, Rebekah A. Freeman et al. · Journal of Medicinal Chemistry · 2001 · 24 citations · Full text

Combinatorial Chemistry, Molecular Pharmacology, Medicinal Chemistry +15